- Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study2018 | Publikace bez příslušnosti k fakultě
- Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal CohortPublikace bez příslušnosti k fakultě
- Prognostický význam ischemií modifikovaného albuminu po perkutánní koronární intervenci2006 | Publikace bez příslušnosti k fakultě
- Prognostický význam ischemií modifikovaného albuminu po perkutánní koronární intervenci2006 | Lékařská fakulta v Hradci Králové
- Prognostic significance of ischemia modified albumin after percutaneous coronary intervention2006 | Lékařská fakulta v Hradci Králové
- Prognostický význam ischemií modifikovaného albuminu po perkutánní koronární intervenci +12006 | 1. lékařská fakulta
- Comparison of One-Year Outcomes in Patients >75 Versus <=75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)2020 | Publikace bez příslušnosti k fakultě
- Polymer-free sirolimus-eluting stent use in Europe and Asia: Ethnic differences in demographics and clinical outcomes2020 | Ústřední knihovna
- Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration2021 | Publikace bez příslušnosti k fakultě
- Three-Year Outcomes of Percutaneous Coronary Intervention With Next-Generation Zotarolimus-Eluting Stents for De Novo Coronary Bifurcation Lesions2014 | 3. lékařská fakulta
- Real-World Safety and Effectiveness Outcomes of a Zotarolimus-Eluting Stent: Final 3-Year Report of the RESOLUTE International Study2013 | 3. lékařská fakulta
- Impact of Body Mass Index on Long-Term Clinical Outcomes After Second-Generation Drug Eluting Stent Implantation: Insights From the International Global RESOLUTE Program2015 | 3. lékařská fakulta
- Bioabsorbable stents in routine practice. New epoch in interventional cardiology2017 | 1. lékařská fakulta
- Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry2019 | Publikace bez příslušnosti k fakultě
- Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial2019 | 3. lékařská fakulta
- 1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration2020 | Publikace bez příslušnosti k fakultě
- One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration2021 | Publikace bez příslušnosti k fakultě
- Unrestricted use of polymer-free sirolimus eluting stents in routine clinical practice2020 | Ústřední knihovna
- Clinical Outcomes of the Resolute Zotarolimus-Eluting Stent in Patients With In-Stent Restenosis2013 | 3. lékařská fakulta
- 1-Year outcomes with COMBO stents in small vessel coronary disease: Subgroup analysis from the COMBO collaboration2020 | Publikace bez příslušnosti k fakultě
- 1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry2020 | Publikace bez příslušnosti k fakultě
- Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison The BVS-EXAMINATION Study (Bioresorbable Vascular Scaffold-A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction)2015 | 3. lékařská fakulta
- Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease2020 | Ústřední knihovna